|
Financial & Legal |
|
Stroke News From Medical News Today
|
Latest Health News and Medical News posted throughout the day, every day.
|
-
Double-Dose Clopidogrel Reduces Risk Of Death, Heart Attack Or Stroke In Patients Undergoing Angioplasty
A double-dose of the anti-clotting treatment clopidogrel, also known as Plavix, significantly reduces complications in heart patients undergoing angioplasty to clear blocked arteries. Shamir R. Mehta, an interventional cardiologist and associate professor of medicine of the Michael G...
-
In A Rat Model Of Stroke, Protecting Nerve Cells From Death
A team of researchers, led by Yizheng Wang, at the Chinese Academy of Sciences, China, has identified a way to preserve nerve cells in a rat model of stroke. Stroke is most commonly caused by impaired delivery of oxygen to part of the brain as a result of disruption to the blood supply (a condition known as ischemia)...
-
New Online Health Test Helps Hispanics Cut Risk Of Heart Disease, Stroke
As families return to the frenzied back-to-school pace, the American Heart Association is urging Hispanics to make time for the most important test they can take: a simple online health assessment to help them avoid heart disease and stroke...
-
Society For Vascular Medicine Features Case Study, Special Section On Peripheral Artery Disease During PAD Awareness Month
One in 20 Americans over age 50 has Peripheral Artery Disease (PAD), a condition that robs them of their independence and mobility by increasing the risk of heart attack, stroke, amputation and death. The Society for Vascular Medicine (SVM) is working to increase awareness of PAD, its diagnosis and treatment...
-
Netherlands Study Shows Need For Dose Management Care When Switching To Generic Statins
Research conducted in the Netherlands has highlighted the need for care when switching patients under treatment for high cholesterol from branded to generic drug families. The study shows that much of the switching can result in patients inadvertently receiving non-equivalent doses, potentially leading to an increased risk of downstream heart disease and stroke...
-
Study Shows Local Standards Of Care Affect The Benefits Of Switching To New Treatement Alternatives
An analysis of a trial into how a new drug dabigatran was effective in preventing stroke in patients with atrial fibrillation has shown that local standards of care affect the benefits of switching to new treatments...
-
Apixaban Success Halts Stroke Prevention Trial
The data monitoring committee of the AVERROES study, seeing overwhelming evidence of the success of apixaban in the prevention of stroke in patients with atrial fibrillation who are unsuitable for the conventional treatment of warfarin, has recommended early termination of this study. The decision came after repeated review and careful consideration of all efficacy and safety data...
-
Stroke Program 'Get With The Guidelines' Could Be Global Model
The American Heart Association/American Stroke Association's Get With The Guidelines® - Stroke program could be a foundation for improving stroke care globally, according to a study published in Circulation: Journal of the American Heart Association. Researchers assessed Get With The Guidelines - Stroke in the Taiwan Stroke Registry with 30,599 stroke admissions between 2006 and 2008...
-
New Global Campaign Aims To Prevent As Many As 1 Million Atrial Fibrillation-Related Strokes
1 Mission 1 Million - Getting to the Heart of Stroke launches announcing a worldwide effort to help prevent as many as 1 million atrial fibrillation (AF)-related strokes through increased awareness and understanding...
-
Genetic Substudy Shows Fewer Major Cardiovascular Events With Ticagrelor (BRILINTA) Regardless Of Relevant Genetic Variability In ACS Patients
A new genetic substudy of PLATO (A Study of PLATelet Inhibition and Patient Outcomes) showed that the effects on a combined primary endpoint of cardiovascular death, myocardial infarction, or stroke seen in Acute Coronary Syndromes (ACS) patients who received the investigational oral antiplatelet treatment, ticagrelor (BRILINTA?), were maintained, whether or not...
|
|
News & Information 
